Latest editorial
Patent profits cannot set the vaccine agenda
Campaigns warn that jab ‘apartheid’ risks global disaster
Staff wait for patients at a new Covid-19 vaccination site at Poets' Corner in Westminster Abbey, London
PRESSURE is growing for the British government and pharmaceutical companies across the globe to end the “vaccine apartheid” of restrictive patents, which deny supplies to poorer countries.
One year on from the World Health Organisation’s (WHO) declaration of the coronavirus pandemic, fresh campaigns have been launched to unlock vaccines for low and middle-income countries and accelerate the end of global restrictions.
Amnesty International is launching its “A Fair Shot” campaign today, urging politicians and pharmaceuticals giants, such as AstraZeneca, Pfizer, BioNTech and Moderna, to share knowledge and technology to maximise the number of doses of vaccines available worldwide.
More from this author
It is ‘unfathomable’ that staff are having to keep doors and windows open and ask pupils to layer up for a second winter, Scottish Teachers for Positive Change and Wellbeing says
Similar stories
Campaigners urge government to stop surrendering our rights and protections to appease the US President
